US Patent Issued to BioNTech on June 30 for "RNA formulations suitable for therapy" (German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,621, issued on June 30, was assigned to BioNTech SE (Mainz, Germany).

"RNA formulations suitable for therapy" was invented by Heinrich Haas (Mainz, Germany), Jorge Moreno Herrero (Mainz, Germany), Anne Marion Genevieve Schlegel (Mainz, Germany) and Stephanie Erbar (Mainz, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions comprising RNA, preferably messenger RNA (mRNA), more preferably self-amplifying RNA (saRNA), and polymers, in particular cationic polymers, such as polyethylenimine (PEI), poly-L-Lysin (PEL), polyvinylamine (PVA) or polyallylamine (PAA), where individual RNA molecules are present i...